Evidence map›Paper›PMID 42882870›Full record

ArticleCancers2026

A Dual-Marker DNA Methylation Assay Enables High-Sensitivity Detection of Malignant Effusions Across Cancer Types.

Ting Wang, Ting Liang, Matthew Kafarski, Jian Liu, Yi Jing, Wen Liao, Hang Xing, Jia Feng, Tingting Bian, Lei Liu and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Ting WangDepartment of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, No. 127 Dongming Road, Jinshui District, Zhengzhou 450008, China.ORCID 0000-0002-4784-8290
Ting LiangDepartment of Pathology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China.ORCID 0009-0006-9723-8120
Matthew KafarskiPrecision Health Program, Department of Radiology, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA.ORCID 0009-0004-2865-0192
Jian LiuDepartment of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, No. 20 Xisi Road, Chongchuan District, Nantong 226001, China.
Yi JingDepartment of Pathology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China.
Wen LiaoDepartment of Pathology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China.
Hang XingRhode Island Hospital, Alpert Medical School of Brown University, Providence, RI 02912, USA.
Jia FengDepartment of Pathology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China.
Tingting BianDepartment of Pathology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China.
Lei LiuDepartment of Pathology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China.
Hui SunDepartment of Pathology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China.
Xiaoli ZhengDepartment of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, No. 127 Dongming Road, Jinshui District, Zhengzhou 450008, China.
Bin SheDirector of Pathology Business Unit, Shanghai ZJ Bio-Tech CO., Ltd., Building 9, No. 2168 Chenhang Hwy, Shanghai 201114, China.
Xiaosha RenDirector of Pathology Business Unit, Shanghai ZJ Bio-Tech CO., Ltd., Building 9, No. 2168 Chenhang Hwy, Shanghai 201114, China.
Joanne LeeDepartment of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, 142 Boren Street, Providence, RI 02912, USA.
Qiushi LinPrecision Health Program, Department of Radiology, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA.
Ming ChenPrecision Health Program, Department of Radiology, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA.ORCID 0000-0002-5773-9848
Liang ChengDepartment of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, 142 Boren Street, Providence, RI 02912, USA.ORCID 0000-0001-6049-5293
Hong GeDepartment of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, No. 127 Dongming Road, Jinshui District, Zhengzhou 450008, China.
Xiaoqun DongPrecision Health Program, Department of Radiology, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA.
Yifei LiuDepartment of Pathology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China.ORCID 0000-0002-4571-2226

Funding

National Natural Science Foundation of China No. 82273422 for Y.L.
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA methylationepigeneticsmalignant effusionRASSF1ASHOX2

Identifiers

PMID42882870
PMCPMC13664152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.